Archer-Daniels-Midland Company (ADM)

Cyclical

FairStock Score: 33/100 — RISKY

Key Financials

Current Price$80.4
Market Cap$32.5B
P/E Ratio35.89
ROE4.77%
Dividend Yield2.57%
SectorConsumer Defensive

Strengths

Concerns

AI Analysis

ADM presents a classic value trap dressed in a defensive sector cloak. I'm troubled by what the numbers reveal. Trading at $67.44 against Graham's intrinsic value of $31.82—a margin of safety of negative 112%—this company demands a significant price cut before becoming interesting. The fundamentals don't justify current valuation. A Piotroski F-Score of just 4/9 signals deteriorating financial condition. ROE of 4.72% and ROCE of 1.71% are abysmal; I'm earning better returns in Treasury bonds. The Altman Z-Score of 1.79 sits dangerously in distress territory. Yes, ADM generates $2.1B in free cash flow and sports a reasonable 0.42 debt-to-equity ratio, but the EV/EBITDA multiple of 44.5x is egregious for a commodity-linked processor. The latest quarter showed $18.6B revenue with merely 2.46% net margins—razor-thin for a business with minimal competitive moat. Agricultural commodity trading is inherently cyclical and competitive; ADM faces constant pressure from larger global players and smaller regional competitors. The business quality simply doesn't justify paying 2.1x book value. I prefer businesses with durable competitive advantages, consistent double-digit returns on equity, and margin of safety. ADM meets none of these criteria at current prices. I'll pass.

Bull Case

ADM benefits from secular tailwinds in global protein demand and renewable energy (biofuels), with management executing portfolio optimization initiatives. The defensive nature of food ingredients provides earnings stability through cycles, potentially justifying premium valuations as investors seek safety.

Bear Case

Commodity pricing pressure and intense competition will continue eroding already-thin margins, while ADM's capital-intensive model generates inadequate returns. Any economic slowdown in livestock or biofuels could trigger significant earnings deterioration, making current valuations untenable.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer